Structural and functional neuroimaging are used along with clinical and cognitive assessments to study patients with schizophrenia and their relatives. Studies can be both cross-sectional and longitudinal, and comparison groups include healthy individuals and their relatives, as well as patients with other psychiatric disorders, especially schizoaffective and bipolar disorder. Our group is also focused on the role of the hippocampal formation in schizophrenia, the treatment effects of oxytocin in patients with water imbalance, and the neurocircuitry of prepulse inhibition in schizophrenia. Clinical trials of new drug treatments are also conducted by our group. In particular, we are interested in testing the efficacy of new drugs that aim to enhance cognition in patients with schizophrenia. We are also surveying family members (mothers and siblings) on how having a relative with schizophrenia has affected their lives.
If interested in current research for individuals with schizophrenia, click here.
If intereted in current research for family members, click here.
If intereted in current research on animal models of schizophrenia, click here.